Skip to main content
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1993 Feb;142(2):375–380.

The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney.

A J Garvin 1, G G Re 1, B I Tarnowski 1, D J Hazen-Martin 1, D A Sens 1
PMCID: PMC1886739  PMID: 8382007

Abstract

The histology, ultrastructure, and messenger RNA expression of heterotransplants derived from the G401 cell line (American Type Culture Collection) have been characterized by comparison with Wilms' and rhabdoid tumors of the kidney. This analysis illustrates that the properties of G401 heterotransplant were consistent with a rhabdoid phenotype rather than that of a Wilms' tumor. The G401 cell line has been utilized in recent experiments to demonstrate the central role of chromosome 11 in Wilms' tumor. However, the present results suggest that these experiments may be more relevant to define the involvement of chromosome 11 in rhabdoid tumor of the kidney, a malignancy distinct from Wilms' tumor. This is clinically relevant since the rhabdoid tumor of the kidney is very aggressive and associated with an extremely poor prognosis.

Full text

PDF
375

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beckwith J. B., Palmer N. F. Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study. Cancer. 1978 May;41(5):1937–1948. doi: 10.1002/1097-0142(197805)41:5<1937::aid-cncr2820410538>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  2. Douglass E. C., Valentine M., Rowe S. T., Parham D. M., Wilimas J. A., Sanders J. M., Houghton P. J. Malignant rhabdoid tumor: a highly malignant childhood tumor with minimal karyotypic changes. Genes Chromosomes Cancer. 1990 Sep;2(3):210–216. doi: 10.1002/gcc.2870020308. [DOI] [PubMed] [Google Scholar]
  3. Dowdy S. F., Fasching C. L., Araujo D., Lai K. M., Livanos E., Weissman B. E., Stanbridge E. J. Suppression of tumorigenicity in Wilms tumor by the p15.5-p14 region of chromosome 11. Science. 1991 Oct 11;254(5029):293–295. doi: 10.1126/science.254.5029.293. [DOI] [PubMed] [Google Scholar]
  4. Dowdy S. F., Lai K. M., Weissman B. E., Matsui Y., Hogan B. L., Stanbridge E. J. The isolation and characterization of a novel cDNA demonstrating an altered mRNA level in nontumorigenic Wilms' microcell hybrid cells. Nucleic Acids Res. 1991 Oct 25;19(20):5763–5769. doi: 10.1093/nar/19.20.5763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dressler G. R., Deutsch U., Chowdhury K., Nornes H. O., Gruss P. Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system. Development. 1990 Aug;109(4):787–795. doi: 10.1242/dev.109.4.787. [DOI] [PubMed] [Google Scholar]
  6. Dressler G. R., Douglass E. C. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1179–1183. doi: 10.1073/pnas.89.4.1179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gansler T., Gerald W., Anderson G., Gramling T. S., Williams C. H., Sens D., Garvin A. J. Characterization of a cell line derived from rhabdoid tumor of kidney. Hum Pathol. 1991 Mar;22(3):259–266. doi: 10.1016/0046-8177(91)90160-q. [DOI] [PubMed] [Google Scholar]
  8. Garvin A. J., Sullivan J. L., Bennett D. D., Stanley W. S., Inabnett T., Sens D. A. The in vitro growth, heterotransplantation, and immunohistochemical characterization of the blastemal component of Wilms' tumor. Am J Pathol. 1987 Nov;129(2):353–363. [PMC free article] [PubMed] [Google Scholar]
  9. Gerald W. L., Gramling T. S., Sens D. A., Garvin A. J. Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor. Am J Pathol. 1992 May;140(5):1031–1037. [PMC free article] [PubMed] [Google Scholar]
  10. Haas J. E., Palmer N. F., Weinberg A. G., Beckwith J. B. Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children. Hum Pathol. 1981 Jul;12(7):646–657. doi: 10.1016/s0046-8177(81)80050-0. [DOI] [PubMed] [Google Scholar]
  11. Hazen-Martin D. J., Chao C. C., Wang I. Y., Sens D. A., Garvin A. J., Wang A. C. Developmental pattern of Thy-1 immunoreactivity in the human kidney and the application to pediatric renal neoplasms. Pediatr Pathol. 1993 Jan-Feb;13(1):37–52. doi: 10.3109/15513819309048191. [DOI] [PubMed] [Google Scholar]
  12. Karnes P. S., Tran T. N., Cui M. Y., Bogenmann E., Shimada H., Ying K. L. Establishment of a rhabdoid tumor cell line with a specific chromosomal abnormality, 46,XY,t(11;22)(p15.5;q11.23). Cancer Genet Cytogenet. 1991 Oct 1;56(1):31–38. doi: 10.1016/0165-4608(91)90359-3. [DOI] [PubMed] [Google Scholar]
  13. Mierau G. W., Beckwith J. B., Weeks D. A. Ultrastructure and histogenesis of the renal tumors of childhood: an overview. Ultrastruct Pathol. 1987;11(2-3):313–333. doi: 10.3109/01913128709048329. [DOI] [PubMed] [Google Scholar]
  14. Nisen P. D., Zimmerman K. A., Cotter S. V., Gilbert F., Alt F. W. Enhanced expression of the N-myc gene in Wilms' tumors. Cancer Res. 1986 Dec;46(12 Pt 1):6217–6222. [PubMed] [Google Scholar]
  15. Re G. G., Antoun G. R., Zipf T. F. Modulation of a constitutive transcriptional block at exon-1 controls human c-myc oncogene expression. Oncogene. 1990 Aug;5(8):1247–1250. [PubMed] [Google Scholar]
  16. Re G. G., Estrov Z., Antoun G. R., Felix E. A., Pinkel D. P., Zipf T. F. Differentiation in B-precursor acute lymphoblastic leukemia cell populations with CD34-positive subpopulations. Blood. 1991 Aug 1;78(3):575–580. [PubMed] [Google Scholar]
  17. Shaw A. P., Poirier V., Tyler S., Mott M., Berry J., Maitland N. J. Expression of the N-myc oncogene in Wilms' tumour and related tissues. Oncogene. 1988 Aug;3(2):143–149. [PubMed] [Google Scholar]
  18. Weeks D. A., Beckwith J. B., Mierau G. W., Luckey D. W. Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms' Tumor Study Pathology Center. Am J Surg Pathol. 1989 Jun;13(6):439–458. [PubMed] [Google Scholar]
  19. Weissman B. E., Saxon P. J., Pasquale S. R., Jones G. R., Geiser A. G., Stanbridge E. J. Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science. 1987 Apr 10;236(4798):175–180. doi: 10.1126/science.3031816. [DOI] [PubMed] [Google Scholar]
  20. Wheeler T. T., Xiao J. P., Dowdy S. F., Stanbridge E. J., Young D. A. Suppression of tumorigenicity of a Wilms' tumor cell line is associated with a decrease in synthesis of two proteins. Oncogene. 1991 Oct;6(10):1903–1907. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES